US20190030102A1 – January 31, 2019 – HYDROGENATION OF CANNABIS OIL

Please complete the required fields.




Inventors :

MARK ANDREW SCIALDONE

Owner :

SCIALDONE, MARK ANDREW

Application Number :

US16117482

Document Number :

US20190030102A1

Priority Date :

August 30, 2018

Filing Date :

August 30, 2018

Date of Grant/ Publication :

January 31, 2019

Class :

A61K36 / 185; A61K31 / 192; A61K31 / 352; C07D311 / 80; A61K31 / 05; A61P35 / 00

Abstract

The present invention relates to the extraction and hydrogenation of essential oil of a cannabis plant. The invention includes hydrogenated cannabis compounds and compositions, as well as methods of preparation and therapeutic uses for regressing tumors in a cancer patient. The extract can include 9-tetrahydrocannabinoic acid and 9-cannabidiolic acid, and the hydrogenated cannabis oil can include hydrogenated 9-tetrahydrocannabinoic acid, hydrogenated 9-cannabidioc acid and, mixtures and blends thereof.

Claim(s)

1 . A method of hydrogenating cannabis oil, comprising: obtaining a cannabis plant having essential oil, comprising at least one of ?-9-tetrahydrocannabinolic acid and ?-9-cannabidiolic acid; extracting the essential oil from the cannabis plant to form an essential oil extract; and hydrogenating the essential oil extract to form hydrogenated cannabis oil, comprising at least one of hydrogenated ?-9-tetrahydrocannabinolic acid and ?-9-cannabidiolic acid.;
7 . A method for regressing tumors in a cancer patient, comprising: preparing a hydrogenated cannabis oil composition, comprising: obtaining a cannabis plant having essential oil, comprising at least one of ?-9-tetrahydrocannabinolic acid and ?-9-cannabidiolic acid; extracting the essential oil from the cannabis plant to form an essential oil extract; and hydrogenating the essential oil extract to form hydrogenated cannabis oil, comprising at least one of hydrogenated ?-9-tetrahydrocannabinolic acid and ?-9-cannabidiolic acid; and administering a therapeutically effective amount of the hydrogenated cannabis oil composition to the cancer patient.;
8 . A hydrogenated cannabis oil composition, comprising a hydrogenated acid selected from the group consisting of hydrogenated ?-9-tetrahydrocannabinolic acid, hydrogenated ?-9-cannabidiolic acid and, mixtures and blends thereof;
9 . A composition, comprising one or more hexahydrocannabinoids selected from the group consisting of formulas 3a, 3b, 3c, 3d, 4a and 4b:;
11 . A method of preparing a hydrogenated cannabis oil, comprising: extracting cannabis oil from a cannabis plant to provide an extract comprising one or more ?-9-tetrahydrocannabinoic acids and ?-9-tetrahydrocannabinols selected from the group consisting of formulas 1a, 1b, 2a and 2b: and hydrogenating the extract to produce a hydrogenated cannabis oil comprising one or more hexahydrocannabinoids selected from the group consisting of formulas 3a, 3b, 3c and 3d:

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login